UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM SD
Specialized Disclosure Report
NOVO NORDISK A/S | ||
(Exact name of the registrant as specified in its charter)
| ||
The Kingdom of Denmark | 333-82318 | N/A |
(State or other jurisdiction of Incorporation or organization) |
(Commission File Number) |
(IRS Employer
|
Novo Allé, DK-2880 Bagsværd, Denmark | N/A | |
(Address of principal executive offices) | (Zip code) |
Jesper Brandgaard | +45 4444 8888 |
(Name and telephone number, including area code, of the person to contact in connection with this report.) |
Check the appropriate box to indicate the rule pursuant to which this form is being filed, and provide the period to which the information in this form applies:
|
☒ Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2016. |
Section 1 - Conflict Minerals Disclosure
Items 1.01 and 1.02 Conflict Minerals Disclosure and Report, Exhibit
Conflict Minerals Disclosure
A copy of Novo Nordisk A/S’s Conflict Minerals Report for the year ended December 31, 2016 is provided as Exhibit 1.01 hereto and is publicly available at http://www.novonordisk.com/sustainability/performance/Transparency-and-disclosure.html
Section 2 – Exhibits
Item 2.01 Exhibits
Exhibit 1.01 – Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.
Date: May 31, 2017 | NOVO NORDISK A/S | |||||
By: | /s/ Jesper Brandgaard | |||||
Name: | Jesper Brandgaard | |||||
Title: | Executive Vice President and Chief Financial Officer | |||||